Related Experiment Video
Updated: May 29, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
The proper effect site concentration of remifentanil for prevention of myoclonus after etomidate injection
Hyun Su Ri1, Sang Wook Shin, Tae Kyun Kim
1Department of Anesthesiology and Pain Medicine, Pusan National University School of Medicine, Yangsan, Korea.
Background:
Etomidate frequently induces myoclonus when administered intravenously with bolus injection during anesthetic induction. This can be bothersome for the anesthesiologist. The dose of remifentanil appropriate for preventing myoclonus without side effects was investigated.
Methods:
All patients with American Society of Anesthesiologists (ASA) physical status I-III were divided into three groups (n = 33 per group) according to the pretreatment effect site concentration of remifentanil (Ultiva, Glaxo-Wellcome, München, Germany) of 0, 2 or 4 ng/ml (Group N: 0 ng/ml, Group R: 2 ng/ml, Group Q: 4 ng/ml) by a target controlled infusion (TCI) system. After a 0.3 mg/kg dose of etomidate was injected intravenously for over 1 minute for anesthetic induction, myoclonus was observed. Before the etomidate injection, the patients were pretreated with remifentanil and their side effects were monitored.
Results:
The number of patients showing myoclonus was significantly different among the groups. The incidence of myoclonus was 81%, 12% and 0% (groups N, R, and Q, respectively, P < 0.01). Side effects including bradycardia and hypotension did not occur in either Group R or Q. Chest wall rigidity occured in 45% of patients in Group Q.
Conclusions:
Administration with a 2 ng/ml effect site concentration of remifentanil could reduce the incidence of myoclonus caused by etomidate bolus injection without chest wall rigidity.
Insights
Remifentanil pretreatment effectively prevents etomidate-induced myoclonus during anesthesia induction. A 2 ng/ml concentration significantly reduced myoclonus incidence without causing adverse effects like bradycardia or hypotension.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Etomidate bolus injection commonly causes myoclonus during anesthetic induction, posing challenges for anesthesiologists.
- Investigating optimal remifentanil dosing is crucial for mitigating this side effect.
Purpose of the Study:
- To determine the effective dose of remifentanil for preventing etomidate-induced myoclonus.
- To assess the safety profile of remifentanil pretreatment at varying concentrations.
Main Methods:
- Patients (ASA I-III) received etomidate (0.3 mg/kg) for induction.
- Three groups were pretreated with remifentanil via target-controlled infusion (TCI) at effect-site concentrations of 0, 2, or 4 ng/ml.
- Myoclonus incidence and side effects were monitored.
Main Results:
- Myoclonus incidence was significantly reduced with remifentanil pretreatment (81% in control vs. 12% at 2 ng/ml and 0% at 4 ng/ml).
- No significant bradycardia or hypotension occurred in the 2 ng/ml or 4 ng/ml groups.
- Chest wall rigidity was observed in 45% of patients in the 4 ng/ml group.
Conclusions:
- A 2 ng/ml effect-site concentration of remifentanil effectively reduces etomidate-induced myoclonus.
- This dose prevents myoclonus without significant adverse cardiovascular effects or chest wall rigidity.
Related Concept Videos
Parenteral Anesthetics: Overview
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Depolarizing Blockers: Pharmocokinetics
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
